DAFTAR PUSTAKA
Al-Hadidy, A.M., Maani, W.S., Mahafza, W.S., Al-Najar, M.S., Al-Nadii, M.M. (2007).
Intracranial Meningioma. J Med J 41(1):37-51.
Al-Mefty, O., Abdulrauf, S.I., Haddad, G.F. 2011. Meningioma. In Youmans Neurological
Surgery, Winn HR (ed), 6thed. New York: Elsevier. pp. 1426-1449.
Al-Rodhan, N.R.F., Laws, E.R. 1991. The History of Intracranial Meningiomas. In
Meningiomas, Al-Mefty (ed). New York: Raven Press. pp. 1-7.
Arbeit, J.M., Olson, D.C., Hanahan, D. Upregulation Of Fibroblast Growth Factors And
Their Receptors During Multi-Stage Epidermal Carcinogenesis In K14-HPV16
Transgenic Mice. (1996). Oncogene (13):1847-1857.
Barnholtz-Sloan, J.S., Kruchko, C. 2007. Meningiomas: Causes and Risk Factors. Neurosurg
Focus. 23 (4): E2.
Bikfalvi, A., Klein, S., Pintucci, G., Quarto, N., Mignatti, P., Rifkin, D.B. Differential
Modulation Of Cell Phenotype By Different Molecular Weight Form Of Basic
Fibroblast Growth Factor: Possible Intracellular Signaling By The High Molecular
Weight Form. (1995). J Cell Biol (129):233-243.
Bikfalvi, A., Klein, S., Pintucci, G., Rifkin, D.B. Biological Roles of Fibroblast Growth
Factor-2 (FGF-2). (1997). Endocr Rev (18):26-45.
Black, P.M., Tariq, F. 2010. Biology Of Meningiomas. In: Pamir, M.N., Black, P.M.,
Fahlbusch, Rudolf., Meningiomas, A Comprehensive Text. New York: Saunders
Elsevier. pp. 121-125.
Black, P.M., Villavicencio, A.T., Rhouddou, C.C., Loeffler, J.S. Aggressive Surgery and
Focal Radiation in The Management of Meningiomas of The Skull Base: Preservation
of Function with Maintanance of Local Control. Acta Neurochir. 2001:143(6):555-62.
Calvocoressi, L., Claus, E.B. 2010. Epidemiology and Natural History of Meningioma. In:
Pamir, M.N., Black, P.M., Fahlbusch, R., (eds). Meningiomas: A comprehensive text.
New York: Saunders Elsevier. pp. 61-77.
Cea-Soriano, L., Wallander, M.A., Garcia-Rodiquez, L.A., 2012. Epidemiology of
meningioma in the United Kingdom. Neuroepidemiology 39 (1): 27-34.
Cha, J.Y., Lambert, Q.T., Reuther, G.W., Der, C.J. Involvement of Fibroblast Growth Factor
Receptor 2 Isoform Switching in Mammary Oncogenesis. Mol Cancer Res.
2008(6):435-445.
Universitas Sumatera Utara
Chin, K., Devries, S., Fridlyand, J. Genomic and Transcriptional Aberations Linked To
Breast Cancer Pathopysiologies. Cancer Cell. 2006(10):529-541.
Chou, S.M., Miles, J.M. 1991. The Pathology of Meningiomas. In Meningiomas, Al-Mefty
O(ed). New York: Raven Press. pp. 4:37-57.
Choy, W., Kim, W., Nagasawa, D., Stramotas, S., Yew, A., Gopen, Q. 2011. The molecular
genetics and tumor pathogenesis of meningiomas and the future directions of
meningioma treatments. Neurosurg Focus(ed6).pp.30.
Christensen, H.C., Kosteljanetz, M.M., Johansen, C.C. Incidences of Gliomas and
Meningiomas in Denmark, 1943 to 1997. Neurosurgery online. 2003;52(6):132733;discussion 1333.
Condra, K.S., Butti, J.M., Mendenhall, W.M., Friedman, W.A., Marcus, R.B., Rhoton, A.L.
Benign Meningiomas: Primary Treatment Selection Affects Survival. Int J Radiat
Oncol Biol Phys. 1997; 39(2):427-436.
Denizot, Y., et al. Short Communication, The Quantitative Analysis of bFGF and VEGF by
ELISA in Human Meningiomas. In: Mediators of Inflamation. Hindawi Publishing
Corporation. Volume 2006, article ID 36376, pages 1-3.
Evans, D.G.R., Watson, C., King, A., Wallace, A.J., Baser, M.E., 2005. Multiple
meningiomas: differential involvement of the NF2 gene in children and adults. J Med
Genet 42: 45-48.
Ezzat, S., Zheng, L., Zhu, X.F., Wu, G.E., Asa, S.L. Targeted Expression of A Human
Pituitary Tumor-Derived Isoform of FGF Reseptor-4 Recapitulates Pituitary
Tumorigenesis. J Clin Invest. 2002; (109):69-78.
Fisher, J.L., Schwartzbaum, J.A., Wrensch, M.W., Wiemels, J.L. Epidemiology of Brain
Tumors. Neurol Clin. 2007; 25(4):867-890.
Haugsten, E.M., Wiedlocha, A., Olsnes, S. Roles Of Fibroblast Growth Factor Receptors in
Carcinogenesis. Mol Cancer Res. 2010; (8):1439-1452.
Igaki H, Maruyama K, Koga T, et al. Stereotactic Radiosurgery for Skull Base Meningioma.
Neurol Med Chir (Tokyo). 2009; 49(10):456-461.
Itoh, H., Hattori, Y., Sakamato, H. Preferential Alternative Splicing In Cancer Generates a Ksam messenger RNA with higher transforming activity. Cancer Res.1994; (54):32373241.
Juldich, P.J., Mc Carthy, B.J., Surawicz, T.S., Freels, S.S., Davis, F.G. Trends in Incidence of
Primary Brain Tumors in United States, 1985-1994. Neuro-oncol. 2001; 3(3):141151.
Universitas Sumatera Utara
Klaeboe, L.L., Lonn, S.S., Scheie, D.D., et al. Incidence of Intracranial Meningiomas in
Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer, 2005; 117(6):9961001.
Krisch M, Santarius T, Black P. Molecular biology of meningiomas and peripheral nerve
sheath tumors. Concepts Neurosurg, 1997; (8):126-45.
Lai, R., Crevier, L., Thabane, L., 2005. Genetic polymorphisms of Glutathione STransferases and the risk of adult brain tumors: A meta-analysis. Cancer epidemiol
biomarkers prev 14 (7): 1784-1790.
Landriel, F., Black, P. 2012. Meningiomas. In: Ellenbogen, R., Abdulrauf, S., Sekhar, L.,
Principles of Neurological Surgery. 3ed. New York: Saunders Elsevier. pp. 541-564.
Li, V.W., Folkerth, R.D., Watanabe, H. Micovessel Count and Cerebrospinal Fluid Basic
Fibroblast Growth Factor In Children With Brain Tumors. Lancet.1994; (344),82-86.
Malmer, B., Feychting, M., Lonn, S., Ahlbom, A., Henriksson, R. 2005. Genotypes and risk
of glioma and meningioma. Cancer epidemiol biomarkers prev 14 (9): 2220-2223.
Marwin, C., Perry, A. 2010. Pathological Classification and Molecular Genetics of
Meningiomas. J Neurooncol. 1999:379-391.
Mathiesen, T.T., Lindquist, C.C., Kihlstrom, L.L., Karlsson, B.B. Recurrence of Cranial Base
Meningiomas. Neurosurgery online. 1996; 39(1):2-7; discussion 8.
McCarthy, B.J., Davis, F.G., Freels, S., et al. Factors Associated With Survival in Patients
With Meningioma. J Neurosurg.1998; 88(5):831-839.
Nakamura, M., Roser, F., Michel, J. The Natural History of Incidental Meningioma.
Neurosurgery. 2003; (53):62-71.
Nakamura, M.M., Roser, F.F., Michel, J.J., Jacobs, C.C., Samii, M.M. The Natural History of
Incidental Meningiomas. Neurosurgery Online. 2003; 53(1):62-70; discussion 70.
Otsuka S., Tamiya T., Ono Y., Michiue H., Kurozumi K., Daido S. 2004. The relationship
between peritumoral brain edema and the expression of vascular endothelial growth
factor and its receptors in intracranial meningiomas. J Neurooncol. (70):349-357.
Pietsch, T., Valter, M.M., Wolf, H.K., et al. Expression And Distribution Of Vascular
Endothelial Growth Factor Protein In human Brain Tumors. Acta Neuropathologica.
1997; 93(2):109-117.
Radhakrisnan, K., Mokri, B., Parisi, J.E., O’Fallon, W.M., Sunku, J., Kurland, L.T. The
Trends in Incidence of Primary Brain Tumors in the Population of Rochester,
Minnesota. Ann Neurol. 1995; 37(1):67-73.
Universitas Sumatera Utara
Ragel, B.T., Couldwell, W.T., Gillespie, D.L., Wendland, M.M., Whang, K., Jensen, R.L. A
Comparison of the cell lines used in meningioma research. Surg Neurol 2008;
70(3):295-307, discussion 307.
Ragel BT, Jensen RL. Pathophysiology of meningiomas. Semin Neurosurg 2003; 85(9):169185.
Rockhill, M., Rugala, M., Chamberlain, M.C. 2007. Intracranial Meningiomas: an overview
of diagnosis and treatment. Neurosurg Focus 23 (4): 1-7.
Sanmoto, K., Ikezaki, K., Ono, M. Expression of Vascular Endothelial Growth Factor And Its
Possible Relation With Neovascularization In Human Brain Tumors. Cancer
Research.1995; 55(5):1189-1193.
Sav, A., Scheithauer, B.W. 2010. Neuropathology Of Meningiomas. In: Pamir, M.N., Black,
P.M., Fahlbusch, Rudolf. Meningiomas, A Comprehensive Text. New York: Saunders
Elsevier. pp. 99-119.
Smith, M.J., Higgs, J.E., Bowers, N.L., Halliday, D., Paterson, J., Gillespie, J. 2011. Cranial
meningiomas in 411 NF2 patients with proven gene mutations: Clear positional effect
of mutations, but absence of female severity effect on age at onset. Journal of Medical
Genetics 48: 1-22.
Taghipour, M., Rakei, S.M., Monabati, A., Nahavandi-Nejad, M., 2007. The role of estrogen
and progesterone receptors in grading of the malignancy of meningioma. IRCMJ 9
(1): 17-21.
Talacchi, A., Corsini, F., Gerosa, M., 2011. Hyperostosing meningiomas of the cranial vault
with and without tumor mass. Acta neurochir 153: 53-61.
Todo, T., Adams, E.F., Fahlbusch, R., Dingermann, T., Werner, H. Autocrine stimulation of
human meningioma cells by platelet derived growth factor. J Neurosurg.1996;
84(5):852-8; discussion 858-859.
Toyokawa, T., Yashiro, M., Hirakawa, K. Co-expression of Keratinocyte Growth Factor and
K-sam is An Indepedent Prognostic Factor In Gastric Carcinoma. Oncol Rep. 2009;
(21):875-880.
Van Havenbergh, T., Carvalho, G., Tatagiba, M., Plets, C., Samii, M. Natural History of
Petroclival Meningiomas. Neurosurgery 2003; 52(1):55-62; discussion 62-74.
Wang, J.L., Nister, M., Hermansson, M., Westermark, B., Ponten, J. Expression of PDGF
beta-receptors in human meningioma cells. Int J Cancer. 1990; 46(5):772-778.
Universitas Sumatera Utara
Wei, Y., Jian, C., Golwa, F.H., Delin, X. Basic Fibroblast Growth Factor And Fibroblast
Growth Factor Receptor-1 In Human Meningiomas. Journal of Huazhong University
of Science and Technology. 2004; 24(1):75-77.
Weisman, A.S., Villemure, J.G., Kelly, P.A. Regulation of DNA synthesis and growth of
cells derived from primary human meningiomas. Cancer Res. 1986: 46(5):2545-2550.
Wiemels, J., Wrensch, M., Claus, E.B. 2010. Epidemiology and etiology of meningioma. J
Neurooncol. 99 (3): 307-314.
Wrensch, M.M., Minn, Y.Y., Chew, T.T., Bondy, M.M., Berger, M.S. Epidemiology of Brain
Tumors: Current Concepts and Review of the Literature. Neuro oncol. 2002;
4(4):278-299.
Universitas Sumatera Utara